View full meeting coverage »

Eyetube Meeting Coverage:

ARDS 2019



Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Anti-VEGF Treatment for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions

  Channels: Retina | Posted 3/5/2019

Mark W. Johnson, MD, sits down with Timothy G. Murray, MD, MBA, to review his talk on the differences between panretinal photocoagulation and anti-VEGF therapy in patients with diabetic retinopathy. Dr. Johnson contrasts differences between the two therapies as long-term treatment options, and discusses data from a pair of studies that examined the visual outcomes of patients with diabetic eye disease who were lost to follow-up for extended periods.

5 / 8 Series: ARDS 2019